by Richard G. Hamermesh - Publications - Faculty & Research - Harvard Business School

Filter Results: (396)

Filter Results: (396)

Show Results For

← Page 11 of 396 Results →

April 1981 (Revised March 1993)
Case

General Electric: Strategic Position--1981

By: Francis Aguilar and Richard G. Hamermesh

Describes the introduction and evolution of General Electric's strategic planning system from the 1960s to Jack Welch's tenure. Allows discussion of the interplay of problems and circumstances to the evolution of the strategic planning system, and how Welch might use... View Details

Keywords: Strategic Planning; Growth Management

November 2012
Supplement

Sugar Bowl, Spreadsheet for Instructors (Brief Case) (CW)

By: Richard G. Hamermesh and Alisa Zalosh

November 2008 (Revised January 2010)
Supplement

Stone Finch, Inc.: Young Division, Old Division, Student Spreadsheet (Brief Case)

By: Richard G. Hamermesh and Elizabeth Collins

Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Behavior; Business Growth and Maturation; Organizations; Human Resources

January 2006 (Revised May 2007)
Supplement

Endo Pharmaceuticals (E): Judge Stein Rules

By: Richard G. Hamermesh and Brian DeLacey

Keywords: Lawsuits and Litigation; Pharmaceutical Industry

December 2003 (Revised September 2004)
Case

Managing Segway's Early Development

By: Richard G. Hamermesh and David Kiron

Describes the early development of the Segway Human Transporter and focuses on the organizational issues that arise between the parent company and the new company that is being spun out to produce and market the Segway. Key issues are the distribution of bonuses and... View Details

Keywords: Business Subsidiaries; Business Startups; Employee Stock Ownership Plan; Resource Allocation; Organizational Design; Technology Adoption

January 2002 (Revised July 2002)
Case

Vialog Corporation

By: Richard G. Hamermesh and Michele Lutz

Traces the origin of Vialog Corp.--from its founding in 1996 through a roll-up of several independent teleconferencing companies in 1997 and its initial public offering (1999) and eventually to a potential merger or acquisition in June 2000. The company has grown... View Details

Keywords: History; Business Exit or Shutdown; Internet and the Web; Corporate Entrepreneurship; Partners and Partnerships; Initial Public Offering; Business Growth and Maturation; Mergers and Acquisitions; Business Processes; Information Technology Industry; Europe

January 2001 (Revised April 2001)
Teaching Note

Lawyers & Leases TN

By: Richard G. Hamermesh and Michele Lutz

Teaching Note for (9-801-166). View Details

Keywords: Contracts; Negotiation; Entrepreneurship; Internet and the Web; Education; Education Industry

August 2013 (Revised October 2013)
Case

MedImmune Ventures

By: Richard G. Hamermesh and David Lane

Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details

Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London

May 2012
Supplement

Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)

By: Richard G. Hamermesh and Alisa Zalosh

November 2012
Supplement

Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)

By: Richard G. Hamermesh and Alisa Zalosh

November 2012
Teaching Note

Sugar Bowl (Brief Case) (TN)

By: Richard G. Hamermesh and Alisa Zalosh

December 2012
Teaching Note

Gene Patents (A) (TN)

By: Richard G. Hamermesh and Matthew Preble

This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details

Keywords: Biotech; Human Genome; Patents; Genetics; Biotechnology Industry; United States

July 2012 (Revised May 2024)
Supplement

Lyric Dinner Theater (B)

By: Richard G. Hamermesh and Jim Sharpe

Supplements the (A) Case. Deborah Denenberg reflects on the results and actions taken during the 12 months following her first 6 months on the job. View Details

Keywords: Entrepreneurs; Entrepreneurial Management; Crisis; Turn; Family Business; Financial Crisis; Boards Of Directors; Operations Management; Strategy Implementation; Career Planning; Entrepreneurship; Entertainment and Recreation Industry; United States

October 2010 (Revised June 2015)
Teaching Note

MINTing Innovation at NewYork-Presbyterian (A) and (B)

By: Richard G. Hamermesh and David Kiron

Teaching Note for 810004 and 815113. View Details

Keywords: Commercialization; Technological Innovation; Health Industry

April 2009
Teaching Note

Amylin Pharmaceuticals: Diabetes and Beyond (TN)

By: Richard G. Hamermesh and Rachel Gordon

Teaching Note for [809011]. View Details

Keywords: Negotiation Deal; Product Development; Success; Commercialization; Governing Rules, Regulations, and Reforms; Resource Allocation; Pharmaceutical Industry

September 2007 (Revised October 2010)
Case

DermaCare: Zapping Zits Directly

By: Richard G. Hamermesh and Lauren Barley

DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details

Keywords: Decision Choices and Conditions; Venture Capital; Investment; Innovation and Invention; Product; California

May 2007
Teaching Note

DentalCorp (TN)

By: Richard G. Hamermesh and Erin Seefeld

Keywords: Health; Health Industry

October 2006 (Revised August 2007)
Case

Calloway Laboratory: Pee for Profit

By: Richard G. Hamermesh and David Kiron

Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details

Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry

May 2006
Teaching Note

WuXi PharmaTech (TN)

By: Richard G. Hamermesh and Erin Seefeld

Keywords: Pharmaceutical Industry

March 2006 (Revised February 2009)
Teaching Note

Molecular Insight Pharmaceuticals, Inc. (TN)

By: Richard G. Hamermesh and Erin Seefeld

Teaching Note to (805-067). View Details

Keywords: Pharmaceutical Industry

←
11
12
…
19
20
→